Ozempic's Major Weight Loss Results in Adults Over 65: A Game Changer for Obesity Treatment Ozempic (semaglutide) has been making headlines for its impressive weight loss results in adults over 65, a demographic often considered high risk for obesity related comorbidities.
Originally developed to treat type 2 diabetes, Ozempic's potential effects on weight loss have sparked significant interest in the medical community. What is Ozempic and How Does it Work?
Ozempic is a glucagon like peptide 1 (GLP 1) receptor agonist that has been used for several years to treat type 2 diabetes.